In fact, leptin signaling pathways interact with the actions of diverse inflammatory molecules including for example, TNF-α, IL-1, IL-2 or IL-6, which can modulate the leptin response, especially in certain pathological situations where there is some degree of inflammation such as obesity, diabetes, or cancer. This evidence concerns the gene LEP and cancer.